> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Teleflex Pacing Guidewire
- URL: https://www.fdaweb.com/fda-clears-teleflex-pacing-guidewire/
- Published: 2020-01-22T12:00:00.000Z
- Updated: 2026-09-14T15:59:31.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5145904

FDA has cleared a Teleflex 510(k) for the Wattson Temporary Pacing Guidewire, a bipolar device designed for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty. The device includes a 0.035-inch pigtailed guidewire that supports valve delivery and allows simultaneous intraventricular bipolar pacing during procedures, Teleflex says. It is also designed, the company adds, to simplify and shorten TAVR procedures by eliminating the need for routine use of central venous access and transvenous temporary pacing catheters.